{"name":"LI ZHAO","slug":"li-zhao","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"rhBNP","genericName":"rhBNP","slug":"rhbnp","indication":"Acute decompensated heart failure","status":"marketed"}]}],"pipeline":[{"name":"rhBNP","genericName":"rhBNP","slug":"rhbnp","phase":"marketed","mechanism":"rhBNP (recombinant human B-type natriuretic peptide) mimics the body's natural natriuretic peptide to promote vasodilation, reduce cardiac preload and afterload, and improve hemodynamics in acute decompensated heart failure.","indications":["Acute decompensated heart failure"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1sSzlkLUFfY29rOXVHLXZqbXgwNzl0UE5HeGR2YTdPVmlfdkNZYkVwaDlUYTlYM2Z4ejlhUkN5dmI1QXVqNUtCZjBvUUhXT0F0Qm1DLUJhd0pyaHNMUTE1Vl9lUXFSVjJicW9nenE2c05xazVMSWc?oc=5","date":"2025-11-05","type":"pipeline","source":"Wiley","summary":"Cancer Biology of GSPT1: Mechanisms and Targeted Therapy Opportunities of Molecular Glue Degraders - Wiley","headline":"Cancer Biology of GSPT1: Mechanisms and Targeted Therapy Opportunities of Molecular Glue Degraders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQYjlBSTJoWTFwdXZQaXFLREU3bEZOTWF5RG04bzFiS0NsWVFnc0tMdW9ZcG1SSmNNV05qLURCenZIWWZlb28yWXQ5X2t1cFgyRTRPMlNBdVNkNGpHN0l4Mm9BM08td0ljZUpFZkc5bExhRFlrMGNZQnFLS3gzRFJmZXlaN0VTVHVLRDBoVzdXcw?oc=5","date":"2025-09-14","type":"pipeline","source":"the-scientist.com","summary":"The Rise of De Novo Genes: From Scratch to Survival - the-scientist.com","headline":"The Rise of De Novo Genes: From Scratch to Survival - the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE5URlRmWjJvUDNTdVdrbE1ldkRuUmJicnUwNDlvRzZEU2xyVkZLay1MSXFUYlpybUp4dWowMmhPcXNGaFZvMTNmbGlKZEhzN0l4aXFDOHYwLUNvVlUyV3Z4TnJEakJuMGhwY003cnZ2WXZxUnJzUk1JUQ?oc=5","date":"2025-07-14","type":"pipeline","source":"The Rockefeller University","summary":"How new genes get switched on - The Rockefeller University","headline":"How new genes get switched on","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5tNzRHN2FjeTdINFZ2Y1RwV21WeFV1dlZxLURKUWJjLUVsNmVmS0dKUlgzN05KaW9LNlZaWFQyR2p4dEpUd3dGQU9KNUNWYkhySkxPM1VjV2t2Zl8wNzZwSUdIRXlJb2F6R0M3THJNejRmaDdHdDFXdUphZw?oc=5","date":"2025-05-30","type":"pipeline","source":"ScienceDirect.com","summary":"The new cocrystal of molnupiravir-caprolactam discovered by melt crystallization with improved tableting properties - ScienceDirect.com","headline":"The new cocrystal of molnupiravir-caprolactam discovered by melt crystallization with improved tableting properties","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxPX3pDV2M3dkNRVHBqM2MzcnFpamcyZDRXQXVfNFdId2JIUlFhVE9TSXdLSDYyOEpDTXJZUjV2OE5DYlNxd0RYdVFnZEtTRnFqYlR5R29uUFBlQjFVbjVFcjFQWk1VbGNxdXdpMWtFeFFjQzVHRzhjc3hwcWtFQkFPOXd3VEtFeDJ5aUJ5WlY3bVlQM2pZNExUd1lRNnZaUVhULTZ2ekV4azVQZFpKNDMxRGdXaTdJM3gxanROaHlfQU5DeWRISW91X09nNXdHT2Npa0puRHhzWFhTOGRxODJmLUQwRndXRHBhQkxJSFhtNnh0VTRUd001M3B2WTFHY2lCcDhzU0NZRy1WcFRsSU5XTTNHYnJCQ2lJYmxOOU52VFFoWURtekROV256S0VoUQ?oc=5","date":"2025-03-10","type":"trial","source":"PR Newswire","summary":"Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity - PR Newswire","headline":"Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Inj","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOcjZpN090Y1k4QVdvajVnWHhqcmtCY2JJMEhGYkVJWWVmV0J5UnVuSWZpc3NxVDRiQ1dwV3ZyUUJvb1QtdFNVTWtDaERZa1dXbm54N1dUZDBteHI5dWhoZnViejctQWZBdWVZNG1uSGd5QlRyaEI3SVl2cWZtNnJRUVJUUkpodUdLaW83ODJLSl9uNkhTalE?oc=5","date":"2025-01-02","type":"pipeline","source":"Frontiers","summary":"Controlling shareholders’ equity pledge and corporate innovation investment—empirical analysis based on pharmaceutical manufacturing - Frontiers","headline":"Controlling shareholders’ equity pledge and corporate innovation investment—empirical analysis based on pharmaceutical m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5RWm9OQlluSXdHdHAtNmR6SWFpVWpMZ3F3UWVuMjZHWlZkcmh6cVBEMVRfVS1pTlJ6WjhNYUZpNmRuY2g5ZGhGU2pSOE9hdHBMcWNSYk5WSVY2OE54a3c?oc=5","date":"2024-06-13","type":"pipeline","source":"ACS Publications","summary":"Diversification of Pharmaceutical Manufacturing Processes: Taking the Plunge into the Non-PGM Catalyst Pool - ACS Publications","headline":"Diversification of Pharmaceutical Manufacturing Processes: Taking the Plunge into the Non-PGM Catalyst Pool","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQR2loYnhNbXh3S0FMUmhqcXBId2N4SVByMUxsT3A1WkVkZ0dXNVJIMUhDMklmaTNOakdjN293aDg5NGljZVpIYW54cklER3hkRVpDeGNfbnI4c20zdEFfWGsyeXRpVHRfWjhweElMYVIxQ05wbVFGa3pJQ0l1eUtFYm5yVS1SS01iWVlSN0VLWGhfdC1UQXRnMFo2VnpwcG1hT2FJSHNCQlNFTWo5bElSbTEyQmc3NV9RZVpSZ19R?oc=5","date":"2023-05-17","type":"pipeline","source":"Forbes","summary":"Pharma Billionaire Zhao Ning Dies At 56 After Battling Cancer For 20 Years - Forbes","headline":"Pharma Billionaire Zhao Ning Dies At 56 After Battling Cancer For 20 Years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBmYzdHUDdSMmlaQ3FydGVhRFJlVTY4dTU1YXVwaVJuU2lKVGwzWXVjSFNGckdZaUlrSXppdVJwVmk3UTJzd0hka3JxY0lJUXdWd3lxZ2FvdWNEeHdwNG5J?oc=5","date":"2023-05-11","type":"pipeline","source":"Nature","summary":"Applications of synthetic biology in medical and pharmaceutical fields - Nature","headline":"Applications of synthetic biology in medical and pharmaceutical fields","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNWDVxUzZkWDBQYkhLRXplWTYxM0NkbEswR1lHQVQtdlhwaXU5RnNoemxJZDdIWklidDMtUVd3VGVXQmtPUnBMbDJ4V0ZDRmN2VEl2STUyTnRtOGhNcXM2S01lX1E2RnRZV1dZNDFNY2NNb1Zvd2Q5X1BrUUEtVjh4b3FMeWMtekxGSHpWRHBxZ21WNFhTZkE?oc=5","date":"2021-05-13","type":"pipeline","source":"Memorial Sloan Kettering Cancer Center","summary":"Memorial Sloan Kettering Announces New Initiative to Focus on Lung Cancer Research - Memorial Sloan Kettering Cancer Center","headline":"Memorial Sloan Kettering Announces New Initiative to Focus on Lung Cancer Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9Hb3ZUbTIycUtwLS1uS3JxbjBURF9ReV9fcGs1MlZtSlkzZWRqN2tZNWhqTm1ia01rdlItaGczU2cycUVvNWkwaFRJZFh3a0Z6bFR3MlA0Mk55Z3ZZdFBBODRfWG11NHRNb0RzSHVYTDJJVjgzUVd0VU9R?oc=5","date":"2020-09-09","type":"pipeline","source":"Columbia University","summary":"Chemical Science Gets $21.5M Boost - Columbia University","headline":"Chemical Science Gets $21.5M Boost","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOeVJZREM2aWZ5bnlkd0dWTTljM3kxa1pIZGRWbnlpSnFuN1pXajgxS0NMRXhnNS1rTC13ZUZhZ1l1cEVmcEM5eHZ6VXUweGdodHlLcUc5RzVfbWdvLVV6MS1ESEdFal9RUHdwRzJuR29oQTZyR0hDa05YbFp0R2pLNElIZGVZWmJ4eG5raTJvTTRSSTA?oc=5","date":"2019-11-27","type":"deal","source":"The Real Deal","summary":"Biotech billionaire pays $26M for 220 CPS pad - The Real Deal","headline":"Biotech billionaire pays $26M for 220 CPS pad","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}